Marshall Wace, LLP Simulations Plus, Inc. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 47,219 shares of SLP stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,219Holding current value
$1.4 Million% of portfolio
0.0%Shares
16 transactions
Others Institutions Holding SLP
# of Institutions
176Shares Held
15.2MCall Options Held
5.4KPut Options Held
1.4K-
Black Rock Inc. New York, NY2.46MShares$73.2 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC1.94MShares$57.5 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$34.2 Million0.0% of portfolio
-
Ranger Investment Management, L.P. Dallas, TX902KShares$26.8 Million1.9% of portfolio
-
State Street Corp Boston, MA640KShares$19 Million0.0% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $603M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...